Article
Targeting BRAF in thyroid cancer.
British journal of cancer - 15 Jan 2007
Espinosa A V, Porchia L, Ringel M D
Abstract excerpt
Activating mutations in the gene encoding BRAF are the most commonly identified oncogenic abnormalities in papillary thyroid cancer. In vitro and in vivo models have demonstrated that overexpression of activated BRAF induces malignant transformation and aggressive tumour behaviour. BRAF and other RAF kinases are frequently activated by other thyroid oncogenes and are important mediators of their biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
